Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
19.65 GBX | +20.92% | +13.13% | +20.43% |
03:42pm | Renalytix's Diabetes, Kidney Disease Test Gets Medicare Final Coverage Determination | MT |
02:23pm | Renalytix Secures Medicare's Final Local Coverage Determination for Kidney Disease Test | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.43% | 32M | |
-51.36% | 2.5B | |
+26.27% | 2B | |
-9.47% | 1.51B | |
+27.23% | 1.33B | |
-16.57% | 960M | |
-1.55% | 802M | |
-30.63% | 793M | |
-23.66% | 640M | |
+18.87% | 577M |
- Stock Market
- Equities
- RENX Stock
- News Renalytix Plc
- Transcript : Renalytix Plc, Q3 2024 Earnings Call, May 15, 2024